title: Where are we now with paracetamol?
authors.affiliation: University/British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK james.dear@ed.ac.uk.
authors.forename: James W
authors.initials: JW
authors.lastname: Dear
authors.affiliation: MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Antoine
authors.affiliation: MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
authors.forename: B Kevin
authors.initials: BK
authors.lastname: Park
mesh_terms: D000082:Acetaminophen / Q000008:administration & dosage / Q000494:pharmacology*; D000410:Alanine Transaminase / Q000187:drug effects*; D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage / Q000494:pharmacology*; D056486:Chemical and Drug Induced Liver Injury / Q000453:epidemiology*; D004334:Drug Administration Schedule; D062787:Drug Overdose / Q000453:epidemiology*; D006801:Humans; D010818:Practice Patterns, Physicians'; D006113:United Kingdom / Q000453:epidemiology
chemical_list: D018712:Analgesics, Non-Narcotic; D000082:Acetaminophen; D000410:Alanine Transaminase